Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor

Emerging evidence suggested that mitophagy may play an important role in the progression of hepatocellular carcinoma (HCC), whereas the association between mitophagy-related genes and HCC patients’ prognosis remains unknown. In this study, we aimed to investigate the potential prognostic values of m...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hao Chen, Jinghua Wang, Ruijie Zeng, Yujun Luo, Kehang Guo, Huihuan Wu, Qi Yang, Rui Jiang, Weihong Sha, Zewei Zhuo
Formato: article
Lenguaje:EN
Publicado: Hindawi Limited 2021
Materias:
Acceso en línea:https://doaj.org/article/888975c01e5c4ff48ef3494e982b5506
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:888975c01e5c4ff48ef3494e982b5506
record_format dspace
spelling oai:doaj.org-article:888975c01e5c4ff48ef3494e982b55062021-11-08T02:36:07ZDevelopment and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor1687-846910.1155/2021/5070099https://doaj.org/article/888975c01e5c4ff48ef3494e982b55062021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/5070099https://doaj.org/toc/1687-8469Emerging evidence suggested that mitophagy may play an important role in the progression of hepatocellular carcinoma (HCC), whereas the association between mitophagy-related genes and HCC patients’ prognosis remains unknown. In this study, we aimed to investigate the potential prognostic values of mitophagy-related genes (MRGs) on HCC patients at the genetic level. According to median immunoscore, we categorized HCC patients from TCGA cohort into two immune score groups, while 39 differential expression MRGs were identified. By using univariate analysis, we screened out 18 survival-associated MRGs, and then, the least absolute shrinkage and selection operator (LASSO) analysis was applied to construct a prognosis model that consisted of 9 MRGs (ATG7, ATG9A, BNIP3L, GABARAPL1, HTRA2, MAP1LC3B2, TFE3, TIGAR, and TOMM70). In our prognostic model, overall survival in the high and low-risk groups was significantly different P<0.001, and the respective areas under the curve (AUC) of our prognostic model were 0.686 for 3-year survival in the TCGA cohort and 0.776 for 3-year survival in the ICGC cohort. Moreover, we identified the risk score as the independent factor for predicting the HCC patients’ prognosis by using single and multifactor analyses, and a nomogram was also constructed for future clinical application. Further functional analyses showed that the immune status between two risk groups was significantly different. Our findings may provide a novel mitophagy-related gene signature, and these will be better used for prognostic prediction in HCC, thus improving patient outcome.Hao ChenJinghua WangRuijie ZengYujun LuoKehang GuoHuihuan WuQi YangRui JiangWeihong ShaZewei ZhuoHindawi LimitedarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal of Oncology, Vol 2021 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Hao Chen
Jinghua Wang
Ruijie Zeng
Yujun Luo
Kehang Guo
Huihuan Wu
Qi Yang
Rui Jiang
Weihong Sha
Zewei Zhuo
Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor
description Emerging evidence suggested that mitophagy may play an important role in the progression of hepatocellular carcinoma (HCC), whereas the association between mitophagy-related genes and HCC patients’ prognosis remains unknown. In this study, we aimed to investigate the potential prognostic values of mitophagy-related genes (MRGs) on HCC patients at the genetic level. According to median immunoscore, we categorized HCC patients from TCGA cohort into two immune score groups, while 39 differential expression MRGs were identified. By using univariate analysis, we screened out 18 survival-associated MRGs, and then, the least absolute shrinkage and selection operator (LASSO) analysis was applied to construct a prognosis model that consisted of 9 MRGs (ATG7, ATG9A, BNIP3L, GABARAPL1, HTRA2, MAP1LC3B2, TFE3, TIGAR, and TOMM70). In our prognostic model, overall survival in the high and low-risk groups was significantly different P<0.001, and the respective areas under the curve (AUC) of our prognostic model were 0.686 for 3-year survival in the TCGA cohort and 0.776 for 3-year survival in the ICGC cohort. Moreover, we identified the risk score as the independent factor for predicting the HCC patients’ prognosis by using single and multifactor analyses, and a nomogram was also constructed for future clinical application. Further functional analyses showed that the immune status between two risk groups was significantly different. Our findings may provide a novel mitophagy-related gene signature, and these will be better used for prognostic prediction in HCC, thus improving patient outcome.
format article
author Hao Chen
Jinghua Wang
Ruijie Zeng
Yujun Luo
Kehang Guo
Huihuan Wu
Qi Yang
Rui Jiang
Weihong Sha
Zewei Zhuo
author_facet Hao Chen
Jinghua Wang
Ruijie Zeng
Yujun Luo
Kehang Guo
Huihuan Wu
Qi Yang
Rui Jiang
Weihong Sha
Zewei Zhuo
author_sort Hao Chen
title Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor
title_short Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor
title_full Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor
title_fullStr Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor
title_full_unstemmed Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor
title_sort development and validation of a novel mitophagy-related gene prognostic signature for hepatocellular carcinoma based on immunoscore classification of tumor
publisher Hindawi Limited
publishDate 2021
url https://doaj.org/article/888975c01e5c4ff48ef3494e982b5506
work_keys_str_mv AT haochen developmentandvalidationofanovelmitophagyrelatedgeneprognosticsignatureforhepatocellularcarcinomabasedonimmunoscoreclassificationoftumor
AT jinghuawang developmentandvalidationofanovelmitophagyrelatedgeneprognosticsignatureforhepatocellularcarcinomabasedonimmunoscoreclassificationoftumor
AT ruijiezeng developmentandvalidationofanovelmitophagyrelatedgeneprognosticsignatureforhepatocellularcarcinomabasedonimmunoscoreclassificationoftumor
AT yujunluo developmentandvalidationofanovelmitophagyrelatedgeneprognosticsignatureforhepatocellularcarcinomabasedonimmunoscoreclassificationoftumor
AT kehangguo developmentandvalidationofanovelmitophagyrelatedgeneprognosticsignatureforhepatocellularcarcinomabasedonimmunoscoreclassificationoftumor
AT huihuanwu developmentandvalidationofanovelmitophagyrelatedgeneprognosticsignatureforhepatocellularcarcinomabasedonimmunoscoreclassificationoftumor
AT qiyang developmentandvalidationofanovelmitophagyrelatedgeneprognosticsignatureforhepatocellularcarcinomabasedonimmunoscoreclassificationoftumor
AT ruijiang developmentandvalidationofanovelmitophagyrelatedgeneprognosticsignatureforhepatocellularcarcinomabasedonimmunoscoreclassificationoftumor
AT weihongsha developmentandvalidationofanovelmitophagyrelatedgeneprognosticsignatureforhepatocellularcarcinomabasedonimmunoscoreclassificationoftumor
AT zeweizhuo developmentandvalidationofanovelmitophagyrelatedgeneprognosticsignatureforhepatocellularcarcinomabasedonimmunoscoreclassificationoftumor
_version_ 1718443204313874432